Related Experiment Video
Updated: May 28, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Respiratory Depression Following Concomitant Infusion of Remimazolam and Remifentanil Using Targeted Effect-Site
Ha Yeon Kim1,2, Sang Kee Min1, Jee Hwan Moon1
1Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, 164 Worldcup-ro, Youngtong-gu, Suwon-si 16499, Gyeonggi-do, Republic of Korea.
Combining remimazolam and remifentanil causes dose-dependent respiratory depression and loss of consciousness (LOC) preceded by desaturation. Continuous monitoring is essential for safe co-administration.
Area of Science:
- Anesthesiology and Pharmacology
Background:
- Remimazolam and remifentanil are ultra-short-acting agents for sedation and analgesia.
- Their combined impact on respiratory function requires investigation.
Purpose of the Study:
- To evaluate dose-dependent respiratory depression and loss of consciousness (LOC) from remimazolam-remifentanil co-administration.
- To determine if LOC is preceded by oxygen desaturation.
Main Methods:
- A randomized, double-blind trial involving 108 female patients undergoing elective gynecological surgery.
- Patients received fixed remimazolam (500 ng/mL Ce) with varying remifentanil concentrations (1.0, 1.5, 2.0 ng/mL Ce).
- Respiratory variables, LOC timing, and adverse events were monitored.
Main Results:
- Respiratory depression increased with higher remifentanil doses.
- Jaw thrust and 100% oxygen requirements escalated significantly with increasing doses.
- Minute ventilation decreased only at the highest remifentanil concentration.
Conclusions:
- Remimazolam-remifentanil co-administration induces dose-dependent respiratory depression.
- Oxygen desaturation can precede loss of consciousness (LOC) during this combination.
- Continuous monitoring and careful dose titration are crucial for patient safety.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...